Ipca Laboratories Ltd has informed BSE that the Company’s formulations manufacturing plant at Piparia (Silvassa, U.T. of D&NH) has been inspected and earned the certificate of
GMP compliance of a manufacturer from Medicines and Healthcare products Regulatory Agency (MHRA-UK).

This certification verifies the quality of the manufacturing operations, quality control, and packaging of the formulations manufactured at this plant. This is the first approval received by Piparia (Silvassa) plant.

In the past, Company’s plant in Kandla (Gujarat) and Athal (Silvassa, U.T. of D&NH) have also been certified with the MHRA-UK approval. Piparia (Silvassa) plant is the third manufacturing plant of the Company to have received such approval.